Skip to main content

Table 2 Prevalence of coronary heart diseases across glycemic categories, by gender: Tehran Lipid and Glucose Study (phase IV: 2008–2011)

From: Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011

  Men Women
Case/Total Crude prevalence % (95% CI) Age-standardized prevalence a
% (95% CI)
Case/Total Crude prevalence % (95% CI) Age-standardized prevalence a
% (95% CI)
NFG/NGT 139/1891 7.35 (6.17–8.53) 7.28 (6.06–8.49) 108/2531 4.27 (3.48–5.05) 5.71 (4.62–6.79)
Prediabetes (IFG or IGT) 126/1000 12.60 (10.54–14.66) 7.95 (6.55–9.36) 88/1040 8.46 (6.77–10.15) 6.62 (5.06–8.19)
DM 133/536 24.81 (21.15–28.47) 13.10 (9.83–16.38) 156/720 21.67 (18.65–24.68) 10.67 (8.90–12.44)
Total 398/3427 11.61 (10.54–12.69) 8.62 (7.81–9.44) 352/4291 8.20 (7.38–9.02) 7.19 (6.46–7.93)
  1. NFG Normal fasting glucose, NGT Normal glucose tolerance, IFG Impaired fasting glucose, IGT Impaired glucose tolerance, DM Diabetes mellitus, CI Confidence interval
  2. aAge-standardized prevalence is calculated based on Iranian population distribution data from the National Consensus Bureau for Tehran province (2010)